DegardinAMorillonDLacourACottenAVermerschPStojkovicT. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol. 2010;39(12):1219-1227.
2.
HochbergMCFeldmanDStevensMB. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986;15(3):168-178.
3.
TymmsKEWebbJ. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol. 1985;12(6):1140-1148.
4.
BohanAPeterJB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403-407.
5.
BohanAPeterJB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-347.
6.
TroyanovYTargoffINTremblayJLGouletJRRaymondYSenecalJL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005;84(4):231-249.
7.
OlsenNJKingLEJrParkJH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am. 1996;22(4):783-796.
8.
VancsaAGergelyLPonyiAMyositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine. 2010;77(2):125-130.
9.
HillCLZhangYSigurgeirssonBFrequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96-100.
10.
MarieILahaxeLBenvenisteOLong-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol. 2010;162(2):337-344.
11.
VandergheynstFOcmantASordetCAnti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients. Clin Exp Rheumatol. 2006;24(2):129-133.
12.
SultanSMIoannouYMossKIsenbergDA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford). 2002;41(1):22-26.
13.
MatsubaraSSawaYTakamoriMYokoyamaHKidaH. Pulsed intravenous methylprednisolone combined with oral steroids as the initial treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry. 1994;57(8):1008.
14.
IorizzoLJ3rdJorizzoJL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008;59(1):99-112.
15.
DanieliMGCalcabriniLCalabreseVMarchettiALogulloFGabrielliA. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev. 2009;9(2):124-127.
